help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2005-1541
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
147/9/4363    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strle, K.
Right arrow Articles by Kelley, K. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strle, K.
Right arrow Articles by Kelley, K. W.
Endocrinology Vol. 147, No. 9 4363-4373
Copyright © 2006 by The Endocrine Society

C-Jun N-Terminal Kinase Mediates Tumor Necrosis Factor-{alpha} Suppression of Differentiation in Myoblasts

Klemen Strle, Suzanne R. Broussard, Robert H. McCusker, Wen-Hong Shen, Julie M. LeCleir, Rodney W. Johnson, Gregory G. Freund, Robert Dantzer and Keith W. Kelley

Laboratories of Immunophysiology (K.S., S.R.B., R.H.M., W.-H.S., J.M.L., K.W.K.) and Integrative Biology (R.W.J.), Department of Animal Sciences, and Department of Pathology, College of Medicine (G.G.F.), University of Illinois, Urbana, Illinois 61801; and Neurobiologie Intégrative (R.D.), Unité Mixte de Recherche Institut National de la Recherche Agronomique-Université de Bordeaux 2, 33077 Bordeaux Cedex, France

Address all correspondence and requests for reprints to: Keith W. Kelley, University of Illinois, Laboratory of Immunophysiology, Department of Animal Sciences, 207 Edward R. Madigan Laboratory, 1201 West Gregory Drive, Urbana, Illinois 61801. E-mail: kwkelley{at}uiuc.edu.

The stress kinase c-jun N-terminal kinase (JNK) was recently shown to be involved in the pathophysiology of major inflammatory conditions, including Alzheimer’s disease, stroke, obesity, and type II diabetes. However, the role of JNK in regulating inflammatory events in skeletal muscle is only beginning to be explored. IGF-I is the major hormone that promotes muscle growth and development. Here we used a novel, JNK interacting protein (JIP)-derived JNK peptide inhibitor to establish that JNK suppresses the biological activity of IGF-I in skeletal muscle progenitor cells. In these myoblasts, TNF{alpha} and its downstream receptor substrates, neutral-sphingomyelinase (N-SMase) and N-acetyl-D-sphingosine (C2-ceramide), induce JNK kinase activity in a time-dependent manner. Consistent with these results, TNF{alpha} induces JNK binding to insulin receptor substrate 1 (IRS-1) but is unable to inhibit IGF-I-induced IRS-1 tyrosine phosphorylation in myoblasts that are treated with the JNK peptide inhibitor. More importantly, JNK activation induced by TNF{alpha}, C2-ceramide, and N-SMase is associated with reduced expression of the critical muscle transcription factor myogenin as well as the differentiation marker myosin heavy chain (MHC). The JNK peptide inhibitor, but not the control peptide, completely reverses this inhibition of both myogenin and MHC. In the absence of IGF-I, TNF{alpha}, C2-ceramide, N-SMase and the JNK inhibitor are inactive, as shown by their inability to affect IRS tyrosine phosphorylation and protein expression of myogenin and MHC. These results establish that the resistance of muscle progenitor cells to IGF-I, which is caused by inflammatory stimuli, is mediated by the JNK stress kinase pathway.




This article has been cited by other articles:


Home page
FASEB J.Home page
H. Shi, J. M. Scheffler, J. M. Pleitner, C. Zeng, S. Park, K. M. Hannon, A. L. Grant, and D. E. Gerrard
Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling
FASEB J, August 1, 2008; 22(8): 2990 - 3000.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. Sell, K. Eckardt, A. Taube, D. Tews, M. Gurgui, G. Van Echten-Deckert, and J. Eckel
Skeletal muscle insulin resistance induced by adipocyte-conditioned medium: underlying mechanisms and reversibility
Am J Physiol Endocrinol Metab, June 1, 2008; 294(6): E1070 - E1077.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. Strle, R. H. McCusker, R. W. Johnson, S. M. Zunich, R. Dantzer, and K. W. Kelley
Prototypical anti-inflammatory cytokine IL-10 prevents loss of IGF-I-induced myogenin protein expression caused by IL-1{beta}
Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E709 - E718.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
R. A. Frost and C. H. Lang
Regulation of muscle growth by pathogen-associated molecules
J Anim Sci, April 1, 2008; 86(14_suppl): E84 - E93.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society